The House recently approved a short-term funding bill that aims to delay restrictions on the intoxicating hemp industry. This decision came with a vote of 370-48, receiving opposition from both 19 Republicans and 29 Democrats. Previously, the Senate had overwhelmingly supported this measure, which now awaits President Trump’s action.
The bill extends the federal ban on many hemp-derived THC products, such as gummies and beverages, until December 11. Industry representatives are considering this development a major victory. They believe this gives them additional time to work on persuading lawmakers to regulate rather than ban these products.
The U.S. Hemp Roundtable emphasized their commitment to using this extension effectively. They prioritize developing a comprehensive federal framework that aims to protect consumers, prevent youth access, provide clarity for businesses and farmers, and ensure lawful access to hemp products.
Products containing cannabinoids that cannot be naturally produced by the Cannabis sativa L. plant will still face a ban starting on November 12. This includes potentially illicit products from China. However, cannabinoids like delta-8 THC, delta-10 THC, and THCP, which can naturally occur in the plant, will remain available at various retail outlets until at least December 11.
Supporters of maintaining the original ban have raised concerns about safeguarding children from products marketed to them under the guise of being hemp while containing high levels of synthetic THC. The synthetic compound in these products is known to induce a high.
The White House has prioritized addressing the hemp ban delay or proposing a regulatory solution, signaling a likely push for legislative action in the coming winter. Administration officials communicated to lawmakers last month that another postponement will not be sought.
In related news, Panorama Produce, based in New York, has issued a recall of mangoes distributed between Aug. 10 and Aug. 21 in New York, New Jersey, Connecticut, and Pennsylvania due to potential salmonella risk.
Meanwhile, President Trump has announced the appointment of Darrell Scott, a pastor and long-standing Trump supporter, as the tobacco health advisor for the CDC. Additionally, Reproductive Freedom for All, along with Senate Majority PAC, has launched a $250,000 campaign against Sen. Susan Collins over her 2018 vote to confirm Justice Brett Kavanaugh.
This newsletter is authored by Nathaniel Weixel and Joseph Choi, focusing on recent healthcare developments in Washington.